Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    51,057.38
    -607.28 (-1.18%)
     
  • CMC Crypto 200

    1,327.83
    -68.71 (-4.92%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Top Ranked Momentum Stocks to Buy for June 15th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, June 15th:

AsburyAutomotive Group, Inc. (ABG): This automotive retailer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 3.9% over the last 60 days.

Asbury Automotive Group, Inc. Price and Consensus

Asbury Automotive Group, Inc. Price and Consensus
Asbury Automotive Group, Inc. Price and Consensus

Asbury Automotive Group, Inc. price-consensus-chart | Asbury Automotive Group, Inc. Quote

Asbury’s shares gained 4.3% over the last one month more than S&P 500’s gain of 1.8%. The company possesses a Momentum Score of B.

Asbury Automotive Group, Inc. Price

Asbury Automotive Group, Inc. Price
Asbury Automotive Group, Inc. Price

Asbury Automotive Group, Inc. price | Asbury Automotive Group, Inc. Quote

ADVERTISEMENT

ABIOMED, Inc. (ABMD): This developer and seller has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 8.4% over the last 60 days.

ABIOMED, Inc. Price and Consensus

ABIOMED, Inc. Price and Consensus
ABIOMED, Inc. Price and Consensus

ABIOMED, Inc. price-consensus-chart | ABIOMED, Inc. Quote

Anadarko Petroleum’s shares gained 15.6% over the last one month. The company possesses a Momentum Score of B.

ABIOMED, Inc. Price

ABIOMED, Inc. Price
ABIOMED, Inc. Price

ABIOMED, Inc. price | ABIOMED, Inc. Quote

AcelRx Pharmaceuticals, Inc. (ACRX): This operator of a specialty pharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 17.4% over the last 60 days.

AcelRx Pharmaceuticals, Inc. Price and Consensus

AcelRx Pharmaceuticals, Inc. Price and Consensus
AcelRx Pharmaceuticals, Inc. Price and Consensus

AcelRx Pharmaceuticals, Inc. price-consensus-chart | AcelRx Pharmaceuticals, Inc. Quote

Altair’s shares gained 40.2% over the last one month. The company possesses a Momentum Score of B.

AcelRx Pharmaceuticals, Inc. Price

AcelRx Pharmaceuticals, Inc. Price
AcelRx Pharmaceuticals, Inc. Price

AcelRx Pharmaceuticals, Inc. price | AcelRx Pharmaceuticals, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
AcelRx Pharmaceuticals, Inc. (ACRX) : Free Stock Analysis Report
 
ABIOMED, Inc. (ABMD) : Free Stock Analysis Report
 
Asbury Automotive Group, Inc. (ABG) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research